The EMA at 20: Trust is the key
This article was originally published in Scrip
Executive Summary
The European Medicines Agency must continue to do all it can to retain the greatest possible public trust, says Emily O'Reilly.
You may also be interested in...
The EMA at 20: Trust is the key
The European Medicines Agency must continue to do all it can to retain the greatest possible public trust, says European Ombudsman Emily O'Reilly.